Journal
CELL DEATH AND DIFFERENTIATION
Volume 24, Issue 1, Pages 120-131Publisher
SPRINGERNATURE
DOI: 10.1038/cdd.2016.104
Keywords
-
Categories
Funding
- Parkinson's UK
- Fundacion Alfonso-Martin Escudero
- Medical Research Council (MRC) [G0700183]
- University College London (UCL)
- Department of Health's NIHR Biomedical Research Centre's funding streams
- MRC [G0700183] Funding Source: UKRI
- Medical Research Council [G0700183] Funding Source: researchfish
Ask authors/readers for more resources
The Parkinson's disease (PD)-related protein F-box only protein 7 (Fbxo7) is the substrate-recognition component of the Skp1Cullin- F-box protein E3 ubiquitin ligase complex. We have recently shown that PD-associated mutations in Fbxo7 disrupt mitochondrial autophagy (mitophagy), suggesting a role for Fbxo7 in modulating mitochondrial homeostasis. Here we report that Fbxo7 deficiency is associated with reduced cellular NAD(+) levels, which results in increased mitochondrial NADH redox index and impaired activity of complex I in the electron transport chain. Under these conditions of compromised respiration, mitochondrial membrane potential and ATP contents are reduced, and cytosolic reactive oxygen species (ROS) production is increased. ROS activates poly (ADP-ribose) polymerase (PARP) activity in Fbxo7-deficient cells. PARP inhibitor restores cellular NAD+ content and redox index and ATP pool, suggesting that PARP overactivation is cause of decreased complex I-driven respiration. These findings bring new insight into the mechanism of Fbxo7 deficiency, emphasising the importance of mitochondrial dysfunction in PD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available